Before an investigator and an industry sponsor begin exchanging information about a clinical trial, a nondisclosure or confidentiality agreement (NDA or CDA) is often requested. This provides protection of proprietary information to allow the investigator and sponsor to freely discuss a protocol in detail.
An EVPRI contract specialist negotiates the NDA terms and conditions, then obtains the signatures of the principal investigator and UofL’s and the sponsor’s authorized representatives.
When the fully executed NDA is in place, the sponsor forwards the study protocol, investigator brochure, draft budget, clinical trial agreement and other study documents for the investigator’s review and consideration.
I Want To Submit: Nondisclosure Agreement for Review